# Pass 2 Cross-Critiques — DCF Analyst
**Date:** 2026-03-09
**Reviewing Analyst:** DCF Analyst
**Subject:** AMD (Advanced Micro Devices, Inc.)

---

## Critique of Research Analyst's Work Product

### 1. Weakest Assumption

**Assumption identified:** "MI450 ships H2 2026 with competitive performance vs. NVIDIA Vera Rubin" [confidence: medium]

**Why it's weak:** The Research Analyst treats MI450 timing as a medium-confidence assumption, but provides no independent verification beyond AMD management's own claims. The SemiAnalysis delay report (mass production Q2 2027) directly contradicts AMD's timeline. The Research Analyst failed to retrieve historical price data, options data, and competitor financials due to tool errors — meaning the data foundation for the entire swarm was incomplete. My DCF bakes in a ~1 quarter delay in base case and significant delay in bear case, but the Research Analyst did not flag the SemiAnalysis report or quantify the delay probability.

**Quantified impact if wrong:** If MI450 delays to Q2 2027, my DCF model shifts ~$3-5B of FY2026-2027 revenue rightward, reducing base case fair value from $154.58 to approximately $135-140 — a ~$15-20/share impact.

**Severity: Medium**

---

### 2. Most Likely Source of Error

**Error source identified:** Incomplete data retrieval — "3-year historical price data — tool error," "Options chain data — tool error," "Full 10-K text — EDGAR CIK resolution failed," "Competitor financials NVDA/INTC" all flagged as DATA GAPs.

**Why this is the most likely error:** These are not estimation gaps but outright retrieval failures. The missing 10-K text means no analyst in the swarm has verified CapEx breakdowns, off-balance-sheet items, or revenue recognition policies from the primary source document. My DCF estimates maintenance vs. growth CapEx based on total CapEx at ~2% of revenue — a split I cannot verify without the 10-K. The missing options data means my 25/50/25 probability weights cannot be cross-checked against market-implied probabilities.

**Suggested correction:** Re-run EDGAR retrieval using the direct filing URL provided in the Data Intelligence Memo (https://ir.amd.com/financial-information/sec-filings). Retrieve options chain data via alternative tools. These are foundational data inputs, not optional enhancements.

**Severity: High**

---

### 3. Recommended Change

**What I'd change:** Add a structured "Data Completeness Score" that explicitly rates data coverage (e.g., 7/12 critical data sources retrieved) so downstream analysts can calibrate their confidence accordingly.

**Why:** The Research Analyst flags individual data gaps but does not aggregate them into an overall reliability assessment. My DCF has 7 data gaps (Section 12), and several trace directly to Research Analyst retrieval failures. Other analysts may not realize how much of their work rests on estimated rather than verified inputs.

**Impact on conclusion:** Would not change the price target directly but would lower conviction on any final rating by flagging that ~30-40% of critical data sources were not retrieved from primary sources.

**Severity: Medium**

---

### 4. What's Strong

The Research Analyst correctly identified the warrant dilution structure (320M shares at $0.01, $600 full vesting) and the CUDA Gap Score (28.7-99.1) as the two most critical qualitative factors — both of which directly inform my DCF scenario probabilities.

---

---

## Critique of Quant Analyst's Work Product

### 1. Weakest Assumption

**Assumption identified:** "NTM EBITDA ~$12,500M at ~27% margin on ~$46B revenue" [ESTIMATED]

**Why it's weak:** The Quant Analyst uses current trailing EBITDA margin (27.2%) to calculate forward EV/EBITDA, but my DCF models FY2026 EBITDA margin at 32.5% (including SBC as cost). The quant's 27% NTM margin assumption creates an artificially high EV/EBITDA multiple (24.6x) that makes AMD look more expensive on this metric than it actually would be if forward margins are used. If NTM EBITDA is $14,700M (32.5% margin on $45.3B revenue per my model), the EV/EBITDA drops from 24.6x to ~21x — changing AMD from "overvalued on EV/EBITDA" to "in-line with comp median of 20.6x."

**Quantified impact if wrong:** Using my DCF's FY2026 EBITDA estimate instead of the quant's NTM EBITDA would shift the EV/EBITDA-implied fair value from ~$162 (quant's estimate at median multiple) to ~$190 — eliminating the apparent 14.9% downside the quant flags.

**Severity: High**

---

### 2. Most Likely Source of Error

**Error source identified:** The comps-implied expected value of $205 is anchored to current-year multiples without adjusting for AMD's significantly faster growth rate relative to the comp group. The PEG ratio (0.51x vs. 1.16x median) is the strongest signal the quant identifies, yet the central estimate of $205 gives it insufficient weight.

**Why this is the most likely error:** A PEG-based fair value with AMD's 55.9% EPS CAGR at the comp group's 1.16x PEG would imply a P/E of ~64.8x — or ~$431/share. Even at a 50% discount to the comp PEG (0.58x), fair value would be ~$230. The quant's blended $205 significantly under-weights the PEG signal relative to the static multiple signals. This is probably because PEG-based valuations are unreliable for extremely high growth rates (55.9% CAGR is unsustainable), but the quant doesn't explicitly address this limitation.

**Suggested correction:** Cap the EPS CAGR used in PEG at a sustainable rate (e.g., 30-35%) to avoid overstating PEG-implied value, then explicitly weight PEG at 20-25% of the blended estimate. This would give a more defensible $210-220 central estimate.

**Severity: Medium**

---

### 3. Recommended Change

**What I'd change:** Adjust the warrant dilution assumption from "partial dilution of ~80M additional shares" to the scenario-dependent dilution I model: 0M (bear), 200M (base), 320M (bull). The quant's single 80M estimate understates dilution in positive scenarios.

**Why:** At the quant's central estimate of $207 undiluted, applying 200M dilution (base case) rather than 80M would reduce the diluted value from ~$197 to ~$185. The quant's dilution-adjusted estimate of $197 is too optimistic because it uses a flat 80M shares across all scenarios rather than recognizing that dilution increases precisely when the stock performs well.

**Impact on conclusion:** Would reduce the quant's dilution-adjusted central estimate from $197 to ~$185, narrowing the gap with my DCF base case of $154.58 but still leaving a $30/share spread that reflects the DCF vs. comps methodological difference.

**Severity: Medium**

---

### 4. What's Strong

The quality score analysis (29.0/100, ROIC 6.6%) is an excellent reality check. My DCF models terminal EBITDA margins of 40.8%, but the quant correctly identifies that AMD's current profitability metrics are the weakest in the comp group ex-Intel. The margin expansion thesis is ambitious and the quality gap supports a lower probability weight on the bull case.

---

---

## Critique of Competitive Analyst's Work Product

### 1. Weakest Assumption

**Assumption identified:** "Custom ASICs and GPUs are complementary, not purely substitutional" [confidence: medium]

**Why it's weak:** My DCF base case assumes 75% mega-deal realization specifically because of ASIC substitution risk. The Competitive Analyst assigns "medium" confidence to ASICs being complementary, but the quantitative evidence undermines this: custom ASIC growth at 44.6% vs. GPU growth at 16.1%, and OpenAI's Broadcom ASIC deal is 67% LARGER than its AMD GPU deal (10 GW vs. 6 GW). If ASICs and GPUs were truly complementary, we would expect similar growth rates. The divergence suggests substitution is already occurring.

**Quantified impact if wrong:** If ASIC substitution reduces mega-deal realization from 75% (base) to 50%, my DCF fair value drops from $154.58 to approximately $120-125 — a ~$30/share downward revision.

**Severity: High**

---

### 2. Most Likely Source of Error

**Error source identified:** AI GPU moat durability rated 5/10 while overall competitive score is 6/10. The moat scoring methodology appears to average across AMD's businesses, but AI GPU is the dominant valuation driver (modeled at 74% of revenue by FY2030 in my DCF). A business-mix-weighted moat score would be closer to 5.5/10.

**Why this is the most likely error:** The server CPU moat (strong, Intel struggling) pulls the average up, but the server CPU business is the slower-growth, lower-value component. The composite score of 6/10 may give false comfort by blending a strong but lower-value franchise with a weak but high-value franchise.

**Suggested correction:** Report a revenue-weighted moat score alongside the simple average. At current mix (48% DC), it would be ~5.5/10. At modeled FY2030 mix (74% DC with GPU dominant), it would converge toward the 5/10 AI GPU rating.

**Severity: Medium**

---

### 3. Recommended Change

**What I'd change:** Quantify the CUDA Gap Score's financial impact. The score of 28.7-99.1 is cited but not translated into revenue or margin terms. In my DCF, the ROCm gap is the primary justification for capping AMD's AI GPU share at 15-20% (vs. theoretical maximum of 30%+).

**Why:** If CUDA gap limits AMD to 12-15% share (as the Competitive Analyst flags as a risk) rather than my base case 18.8%, Data Center revenue in FY2030 would be ~$55-60B instead of $73.1B — a ~$20B revenue difference with cascading margin and valuation impacts.

**Impact on conclusion:** Would translate the competitive analysis into quantified financial impact, directly informing DCF scenario weights. Currently, the competitive score is qualitative — making it difficult to integrate into a financial model.

**Severity: Medium**

---

### 4. What's Strong

The identification of the "dual squeeze" (NVIDIA CUDA moat from above + custom ASIC cannibalization from below) at 60% probability in 3 years is the most important competitive insight. This framing directly validates my DCF's bearish skew and the 0.31x upside/downside ratio.

---

---

## Critique of Macro Analyst's Work Product

### 1. Weakest Assumption

**Assumption identified:** "AI capex cycle has 12-24 months of strong growth remaining before deceleration" [confidence: medium]

**Why it's weak:** The Macro Analyst's 12-24 month estimate for AI capex continuation directly conflicts with my DCF, which models strong Data Center growth through FY2028 (55.4B) before decelerating to 8.2% growth in FY2030. If AI capex peaks in 12-18 months (by mid-2027), my FY2028-2030 Data Center projections are fundamentally too high. The Macro Analyst cites a 25-28:1 capex-to-revenue ratio (6-7x telecom bubble), which is a powerful data point — but then assigns only "medium" confidence to the cycle timing. The telecom bubble comparison alone warrants lower confidence in sustained capex beyond 2027.

**Quantified impact if wrong:** If AI capex peaks in mid-2027, my FY2028 DC revenue of $55.4B could fall to ~$40B (still growing but decelerating sharply). This would reduce base case fair value from $154.58 to approximately $115-125.

**Severity: High**

---

### 2. Most Likely Source of Error

**Error source identified:** The probability-weighted macro-adjusted fair value of "~$190 (flat to current)" appears to be outcome-weighted rather than risk-adjusted. The Macro Analyst's own scenario weights show 30% bull ($280-320), 40% base ($180-220), 20% bear ($110-140), 10% catastrophic ($70-90). The arithmetic EV of these midpoints is approximately: (0.30 x $300) + (0.40 x $200) + (0.20 x $125) + (0.10 x $80) = $90 + $80 + $25 + $8 = $203 — not ~$190.

**Why this is the most likely error:** Either the Macro Analyst applied some risk adjustment that isn't shown, or the "$190" figure is an approximation that doesn't match their own scenario math. This matters because my DCF's probability-weighted value of $154 and the Macro Analyst's ~$190-203 will be compared in synthesis — the $40-50 gap should be reconciled.

**Suggested correction:** Show the explicit expected value calculation with midpoint prices for each macro scenario so the Director can see whether the ~$190 is arithmetic or risk-adjusted.

**Severity: Medium**

---

### 3. Recommended Change

**What I'd change:** Map the macro scenarios to specific DCF line items rather than giving aggregate price ranges. For example: "Hormuz crisis → +200bps to WACC for 6 months → -$X/share; AI capex correction → -30% DC revenue in FY2028 → -$Y/share."

**Why:** My DCF sensitivity table already shows WACC sensitivity ($136-$193 at 16% WACC depending on terminal growth). The Macro Analyst's rate shock scenario ("+200bps") could be directly mapped to my WACC sensitivity: WACC 18% implies ~$109-$144, which is consistent with the macro bear case of $110-$140. Making this linkage explicit would strengthen both analyses.

**Impact on conclusion:** Would allow the Director to integrate macro scenarios directly into the DCF framework rather than treating them as independent overlays.

**Severity: Low**

---

### 4. What's Strong

The 25-28:1 AI capex-to-revenue ratio is the single most important macro data point in the swarm. It directly justifies the 25% bear case probability in my DCF — if we are in another speculative infrastructure buildout, the correction will be severe and my bear case $84 may still be too optimistic.

---

---

## Critique of Credit Analyst's Work Product

### 1. Weakest Assumption

**Assumption identified:** "Total debt: $3,300M" — this conflicts with the $4,010M total debt figure in my DCF (sourced from AMD-market-data.json).

**Why it's weak:** The $710M discrepancy ($4,010M vs. $3,300M) likely reflects different measurement dates or definitions (e.g., including/excluding the $875M Sep 2026 notes in near-term vs. long-term classification). My DCF uses $4,010M from market data (Tier 4); the Credit Analyst cites AMD 10-K/A (Tier 1). If the Credit Analyst's $3,300M is correct, my DCF understates equity value by ~$710M / 1,860M shares = ~$0.38/share — immaterial, but the inconsistency should be resolved because it suggests one of us is using stale or incorrect data.

**Quantified impact if wrong:** $0.38/share — negligible. But the data inconsistency flags a broader issue: if debt figures disagree, what other financial inputs have discrepancies between analysts?

**Severity: Low**

---

### 2. Most Likely Source of Error

**Error source identified:** The $12.2B purchase commitments ($8.5B in FY2026) with TSMC are flagged as a risk but not quantified in terms of cash flow impact under stress.

**Why this is the most likely error:** My DCF assumes negative working capital changes of $530M-$870M per year, but if AI demand collapses and AMD must absorb $2-4B in take-or-pay TSMC commitments (as the Credit Analyst estimates), my FCF in FY2026-2027 would be materially lower. This is a gap in my own model that the Credit Analyst correctly identifies but doesn't fully quantify. The bear case FCF should incorporate a one-time $2-4B working capital hit from excess TSMC inventory.

**Suggested correction:** Model a "demand collapse" scenario where $3B of TSMC commitments become excess inventory, reducing FY2027 FCF from $15.8B to ~$12.8B. This would reduce bear case fair value by approximately $5-8/share.

**Severity: Medium**

---

### 3. Recommended Change

**What I'd change:** Incorporate the Credit Analyst's $13.6B total liquidity figure and M&A capacity ($15-23B before exceeding 1.0-2.0x leverage) into the DCF as a potential value driver. My DCF models zero M&A, but AMD's M&A capacity is a real option that has value — particularly if it can acquire ROCm-enhancing software companies to close the CUDA gap.

**Why:** The credit analysis confirms AMD has substantial dry powder. While M&A is inherently unpredictable, the optionality has value that a DCF ignores. Even a modest 5% probability of a $5B accretive acquisition adds ~$3-5/share in expected value.

**Impact on conclusion:** Would modestly increase fair value by $3-5/share in the base case, partially offsetting the TSMC commitment risk.

**Severity: Low**

---

### 4. What's Strong

The Credit Analyst's conclusion that "if AMD stumbles, it will be on execution, not credit" is exactly right and directly informs my DCF. The balance sheet strength means my bear case is driven by revenue/margin disappointment and multiple compression, not financial distress — which is why my bear case is $84 (not $40-50 like a leveraged company).

---

---

## Critique of Risk Analyst's Work Product

### 1. Weakest Assumption

**Assumption identified:** "Expected value: $210.00 (Bull $280/25%, Base $220/50%, Bear $120/25%)"

**Why it's weak:** The Risk Analyst's scenario prices are materially higher than my DCF in every case: Bull $280 vs. my $223, Base $220 vs. my $155, Bear $120 vs. my $84. The $55-65/share gap in the base case is enormous. The Risk Analyst does not disclose the methodology behind these price targets — are they multiples-based, DCF-based, or judgment-based? Without methodological transparency, these numbers appear to be top-down estimates untethered from a financial model.

**Quantified impact if wrong:** If the Risk Analyst's $210 EV is used instead of my $154 for position sizing, the Kelly fraction is 39.5% (vs. negative Kelly at my price). This would lead to a dramatically different position recommendation — potentially a large overweight based on numbers that are $55/share above my model output.

**Severity: High**

---

### 2. Most Likely Source of Error

**Error source identified:** "Annualized volatility: ~55% [ESTIMATED]" and "Correlation to SPX rises to 0.85+ in selloffs" — these are estimated, not computed from actual data (acknowledged as a data gap).

**Why this is the most likely error:** The Risk Analyst acknowledges the historical price data was not retrieved. This means the volatility, correlation, and drawdown estimates are qualitative. My WACC uses an observed beta of 2.02, which implies annualized systematic volatility of ~2.02 x ~15% (SPX vol) = ~30% systematic + idiosyncratic. Total vol of ~55% is plausible but unverified. If actual vol is lower (40-45%), the risk-adjusted return improves; if higher (60%+), it deteriorates.

**Suggested correction:** Retrieve actual historical price data and compute realized volatility, beta, and correlation from at least 3 years of daily returns. The estimated figures are reasonable but should be verified before position sizing decisions.

**Severity: Medium**

---

### 3. Recommended Change

**What I'd change:** Reconcile the Risk Analyst's $210 expected value with my DCF's $154. The $56/share gap is the largest inter-analyst disagreement in the swarm and will confuse the Director if not addressed. The Risk Analyst should disclose whether the $210 reflects a lower WACC, higher revenue estimates, different scenario weights, or a fundamentally different methodology.

**Why:** Two analysts in the same swarm producing $154 and $210 expected values (a 36% divergence) undermines the credibility of both outputs. The divergence likely stems from the Risk Analyst using higher scenario prices without running a DCF, but this should be made explicit.

**Impact on conclusion:** If the Risk Analyst's $210 is methodology-agnostic (judgment-based), the Director should weight my DCF-derived $154 more heavily for price target purposes, while using the Risk Analyst's output for risk management (position sizing, drawdown analysis, correlation).

**Severity: High**

---

### 4. What's Strong

The drawdown analysis (30%+ drawdowns ~1.5x per year, max expected drawdown -45% to -55%) is directly useful for position sizing and stop-loss calibration. The asymmetric beta observation (realized beta 2.4x in 2022 selloff vs. 2.02 average) validates my decision to use the higher observed beta rather than a forward-looking estimate.

---

---

## Critique of Catalyst Analyst's Work Product

### 1. Weakest Assumption

**Assumption identified:** "MI450 ramp EV: +5.9% (30% on-time strong/+25%, 45% on-time limited/+7.5%, 25% delay/-20%)"

**Why it's weak:** The Catalyst Analyst assigns 75% probability (30% + 45%) to MI450 shipping on time in Q3 2026. My DCF base case assumes a ~1 quarter delay, and the SemiAnalysis report (cited by the Catalyst Analyst themselves) suggests mass production Q2 2027. The 75% on-time probability seems inconsistent with the analyst's own acknowledgment that "SemiAnalysis delay report vs. AMD's 'BS' denial creates genuine informational uncertainty." If the truth lies between Q3 2026 and Q2 2027 (as the Catalyst Analyst states), the on-time probability should be closer to 40-50%, not 75%.

**Quantified impact if wrong:** If on-time probability drops from 75% to 50%, the MI450 catalyst EV drops from +5.9% to approximately +2.5% — reducing the time-weighted 12-month expected return from +25-40% to +15-30%.

**Severity: Medium**

---

### 2. Most Likely Source of Error

**Error source identified:** "Time-weighted 12-month expected return: +25-40% — IF catalysts stack positively" — the conditional "IF" carries enormous weight that could be underappreciated.

**Why this is the most likely error:** The catalyst analysis implicitly assumes positive catalyst correlation (catalysts stacking positively). But my DCF shows that the current price already embeds successful catalyst realization. If MI450 ships on time AND mega-deals ramp as expected, the upside is +17% (to $223) — not +25-40%. The Catalyst Analyst's higher return estimate likely reflects re-rating potential beyond my DCF fair value, but this should be made explicit. There's a risk the Director reads "+25-40%" and overweights the bullish case.

**Suggested correction:** Separate the expected return into (a) catalyst-driven earnings revision, and (b) re-rating/multiple expansion. The earnings component should be cross-checked against my DCF scenario prices. Only the multiple expansion component represents return above fundamental value.

**Severity: Medium**

---

### 3. Recommended Change

**What I'd change:** Add the negative catalyst of "NVIDIA Vera Rubin early shipment" (40% probability, -5-10%) to the base case weighted return rather than treating it only as a risk. My DCF assumes NVIDIA maintains >80% GPU share precisely because of CUDA + Vera Rubin competitive response. If Vera Rubin ships early AND performs well, AMD's MI450 window narrows, reducing mega-deal realization rates below my base case 75%.

**Why:** The catalyst analysis is asymmetrically positive — positive catalysts are probability-weighted into expected returns, but negative catalysts appear only in the risk section. A balanced catalyst EV should net positive and negative catalysts.

**Impact on conclusion:** Netting negative catalysts (Vera Rubin -5-10% x 40% = -2-4%; AI capex correction -20-35% x 20% = -4-7%) against positive catalysts would likely reduce the 12-month expected return from +25-40% to +10-25%.

**Severity: Medium**

---

### 4. What's Strong

The phased entry strategy (1/3 now, 1/3 post-Q1 earnings, 1/3 on MI450 confirmation) is the most actionable recommendation in the swarm and directly addresses the timing uncertainty that my DCF cannot capture. This should be incorporated into the final position sizing recommendation.

---

---

## Critique of Devil's Advocate's Work Product

### 1. Weakest Assumption

**Assumption identified:** "DA-adjusted EV: $178.00; Bull $300/20%, Base $200/45%, Bear $80/35%"

**Why it's weak:** The DA's bull case of $300 is 34% above my DCF bull case of $223. A $300 price target requires either a significantly lower WACC (~11-12%) or revenue/margin assumptions far above my bull case ($130B revenue, 60% GM, 45% EBITDA margin). The DA doesn't explain how $300 is derived — if it's a placeholder to demonstrate that even with extreme upside, the risk/reward is poor, that's fine, but it inflates the expected value calculation and makes the -6.5% expected return look less negative than it would with my DCF-derived $223 bull case.

**Quantified impact if wrong:** Using my DCF's $223 bull case instead of the DA's $300: EV = (0.20 x $223) + (0.45 x $200) + (0.35 x $80) = $44.60 + $90 + $28 = $162.60. Expected return = -14.6% (vs. DA's -6.5%). The Kelly fraction would be even more negative — strengthening, not weakening, the DA's own bearish conclusion.

**Severity: Medium**

---

### 2. Most Likely Source of Error

**Error source identified:** "Composite fragility score: 4.2/5 — EXTREMELY FRAGILE" implies the thesis requires all five critical assumptions to hold simultaneously. But my DCF shows the base case ($155) is achievable with only partial assumption fulfillment: 75% mega-deal realization, 1-quarter MI450 delay, ROCm "adequate" (not great), and moderate margin expansion.

**Why this is the most likely error:** The DA conflates the bull case fragility (which IS extremely fragile — requiring simultaneous MI450 success, mega-deal execution, ROCm gap closure, AND margin expansion) with the overall thesis fragility. The base case is more robust: it allows for partial failure on multiple dimensions. A more nuanced fragility score would rate the bull case 4.5/5 but the base case at 2.5-3.0/5.

**Suggested correction:** Provide scenario-specific fragility scores rather than a single composite. The bear case should arguably score LOW on fragility (only requires one or two things to go wrong), which supports the DA's overall conclusion even more strongly.

**Severity: Medium**

---

### 3. Recommended Change

**What I'd change:** The DA's bear case of $80 is very close to my DCF bear case of $84 — this convergence should be highlighted as a consensus point. But the DA assigns 35% probability to the bear case vs. my 25%. The 10pp difference is meaningful: at 35% bear probability, my probability-weighted value would drop from $154 to ~$140. The DA should justify why 35% is more appropriate than 25% with specific evidence.

**Why:** The bridge contract thesis and ASIC substitution risk are well-argued, but the 35% probability seems to reflect the DA's role (maximize bear case) rather than calibrated probability. OpenAI and Meta have both signed binding commitments with deployment milestones — completely writing these off at 35% probability requires evidence that these commitments are non-binding or easily restructured.

**Impact on conclusion:** The 10pp bear probability difference drives a ~$14/share gap in expected value. The Director needs to decide whether the DA's 35% or my 25% is more appropriate — the answer depends on how binding the mega-deal contracts are, which is a [DATA GAP].

**Severity: Medium**

---

### 4. What's Strong

The pre-mortem analysis ("$80 by March 2028 if mega-deals are bridge contracts + AI capex correction") is the most valuable contribution from the DA. It precisely describes the failure mode that my DCF bear case models. The convergence between the DA's $80 pre-mortem and my $84 bear case lends confidence to the bear case floor estimate.

---

---

## Critique of ESG & Governance Analyst's Work Product

### 1. Weakest Assumption

**Assumption identified:** "Expected dilution: (0.30 x 0%) + (0.45 x 9.8%) + (0.25 x 19.6%) = 9.3%"

**Why it's weak:** The ESG Analyst's dilution probabilities (30%/45%/25%) don't align with my DCF's scenario structure. My model uses 0M shares (bear/25%), 200M shares (base/50%), 320M shares (bull/25%). The ESG Analyst's 30% probability of zero vesting vs. my 25% seems minor, but the 45% probability of 50% vesting vs. my 50% probability of ~63% vesting (200M of 320M) creates a meaningful difference. My expected dilution is: (0.25 x 0%) + (0.50 x 12.0%) + (0.25 x 19.3%) = 10.8% — vs. the ESG Analyst's 9.3%. The 1.5pp gap translates to a ~$3/share valuation difference.

**Quantified impact if wrong:** ~$3/share — modest but worth reconciling, especially since the dilution methodology should be consistent across the swarm.

**Severity: Low**

---

### 2. Most Likely Source of Error

**Error source identified:** "Warrant issuance relied on 'inducement grant' exception or commercial arrangement classification under NASDAQ rules [DATA GAP: exact rule not confirmed]"

**Why this is the most likely error:** This is a governance risk that could have legal/regulatory consequences if the NASDAQ classification is challenged. However, for DCF purposes, the warrants exist regardless of how they were authorized. The more relevant question for my model is: can the warrant pool GROW? The ESG Analyst flags "no cap on total warrant commitments has been disclosed" — which is a risk to future dilution beyond the 320M shares I model. If AMD signs a third mega-deal with, say, Google, and issues another 160M warrants, total potential dilution increases from 320M to 480M shares.

**Suggested correction:** Model a "warrant creep" scenario where additional mega-deals add 100-200M more warrants over the forecast period. This would further compress bull case upside in my DCF.

**Severity: Medium**

---

### 3. Recommended Change

**What I'd change:** The ESG WACC adjustment of "+10-15bps for governance structure risk" should be explicitly incorporated into my DCF sensitivity. At WACC 16.1% (vs. 16.0%), the impact is ~$1/share — negligible. But this confirms that ESG/governance factors are immaterial to the DCF, which is itself a useful finding for the Director.

**Why:** The Director needs to know that governance concerns (warrant process, combined Chair/CEO) are qualitatively important but quantitatively immaterial to the fair value estimate. The ESG Analyst's own WACC adjustment confirms this.

**Impact on conclusion:** Minimal (~$1/share). The governance concerns are legitimate but priced into the warrant dilution adjustment, not the discount rate.

**Severity: Low**

---

### 4. What's Strong

The identification that the warrant structure "creates adverse asymmetry for existing shareholders" perfectly mirrors my DCF conclusion that "dilution is functionally a tax on success." This convergence from independent governance and financial analysis strengthens the finding.

---

---

## Critique of Forensic Analyst's Work Product

### 1. Weakest Assumption

**Assumption identified:** "$306M reserve release is legitimate reversal related to MI308 export license resolution [ASSUMPTION based on timing]" [confidence: medium-high]

**Why it's weak:** My DCF uses Q4 2025 non-GAAP GM of 57% as the basis for forward margin assumptions, but I explicitly note that "$306M inventory reserve release — normalized Q4 GM ~54%." The Forensic Analyst assigns medium-high confidence to the release being legitimate, but the timing raises questions: AMD took the charge when China restrictions hit, then reversed it when MI308 received an export license — this is mechanically correct, but the pattern of charge-then-release creates GM volatility that could recur. If Q1 2026 guided GM is 55%, the underlying trajectory is 54-55%, not 57%.

**Quantified impact if wrong:** If my terminal gross margin should be 55% (tracking the underlying 54-55% trajectory) instead of 57.5%, terminal EBITDA margin drops by ~250bps. At WACC 16%, this reduces base case fair value from $154.58 to approximately $140-145 — a ~$10-15/share impact.

**Severity: Medium**

---

### 2. Most Likely Source of Error

**Error source identified:** "Goodwill + Intangibles: $41,831M = 54.4% of total assets — declining from 67.2% FY2023." The Forensic Analyst notes goodwill impairment risk is "negligible while market cap ($310B) = 6.3x Xilinx purchase price ($49B)." But my DCF bear case implies an equity value of $139B — still well above $49B, so impairment risk is low even in the bear case.

**Why this is the most likely error:** It's not an error per se — the Forensic Analyst is correct that impairment risk is low. However, the 54.4% goodwill/intangibles concentration means AMD's "real" tangible asset base is only ~$35B against $310B market cap. In a deep bear case (which my DCF doesn't model but the Risk Analyst's multi-factor worst case does at $57-76), tangible book value provides almost no support. The Forensic Analyst should flag that the floor valuation in an extreme scenario is far below the $84 bear case.

**Suggested correction:** Add a "catastrophic floor" estimate based on tangible book value + discounted future cash flows in a run-off scenario. This would inform the tail risk analysis.

**Severity: Low**

---

### 3. Recommended Change

**What I'd change:** The GAAP/Non-GAAP EPS gap of $1.52/share ($2.65 vs. $4.17) should be contextualized against my DCF's treatment of SBC. My model treats SBC as a real operating expense (deducted from FCF), which is the GAAP-aligned approach. But the market trades AMD on non-GAAP earnings (which adds SBC back). This means my DCF's implied P/E multiples (Section 10) use non-GAAP EPS for consistency with market pricing — the Forensic Analyst should flag whether this creates a double-counting risk if SBC is both deducted from FCF AND used to compute a non-GAAP P/E cross-check.

**Why:** There is no double-counting in my model (SBC is deducted from FCF in the DCF, and the implied P/E cross-check using non-GAAP EPS is just a reasonableness test, not a valuation input). But the Forensic Analyst should confirm this distinction explicitly, as GAAP/non-GAAP confusion is one of the most common errors in semiconductor valuation.

**Impact on conclusion:** No direct impact if my model handles it correctly (it does), but important for quality control.

**Severity: Low**

---

### 4. What's Strong

The Beneish M-Score of -2.71 (well below -1.78 threshold) and CFO/NI ratio of 1.79x are clean signals that AMD's earnings quality is genuinely strong. This gives me confidence that the revenue and margin inputs to my DCF are based on real economic activity, not accounting manipulation.

---

---

## Critique of Sentiment Analyst's Work Product

### 1. Weakest Assumption

**Assumption identified:** "Lisa Su's guidance beat rate (6+ consecutive quarters) will continue near-term" [confidence: high]

**Why it's weak:** My DCF base case models revenue 7-10% above Q1 guidance ($9.8B guided vs. the implied ~$10.5-11B quarterly run-rate needed to reach $45.3B FY2026). If Lisa Su is still under-promising, my model may be too conservative. But the Sentiment Analyst also notes Su's "shift from conservative to ambitious public targets (>60% DC CAGR, >$20 EPS)" — which contradicts the under-promise pattern. You cannot simultaneously be under-promising AND setting unprecedented aspirational targets. The high confidence in continued beats ignores this inflection in Su's communication style.

**Quantified impact if wrong:** If Q1 2026 revenue merely meets guidance ($9.8B) rather than beating by the historical ~5-7% pattern, FY2026 revenue could track ~$42-44B instead of my $45.3B — reducing base case fair value by ~$5-10/share.

**Severity: Medium**

---

### 2. Most Likely Source of Error

**Error source identified:** "Refusal to disclose Instinct GPU revenue (MEDIUM-HIGH severity) — core thesis driver has no disclosed revenue"

**Why this is the most likely error:** The Sentiment Analyst is right that this opacity is a red flag. My DCF estimates DC GPU revenue at ~$8,300M for FY2025 (50% of DC segment) — this is entirely [ESTIMATED]. If actual GPU revenue is materially lower (say $6-7B), my GPU growth trajectory is overstated because the base is lower. Conversely, if GPU revenue is higher ($9-10B), the growth rate to my FY2030 target is less steep. Either way, the lack of disclosure creates a wide confidence interval on the single most important revenue line in my model.

**Suggested correction:** The Sentiment Analyst should explicitly recommend that the Director flag "GPU revenue unknown" as a Key Unresolved Risk. Any price target derived from my DCF is conditional on an estimated GPU revenue split that AMD deliberately does not disclose.

**Severity: High**

---

### 3. Recommended Change

**What I'd change:** Integrate the Q&A hedging density increase (+76% vs. prepared remarks) into the catalyst timing analysis. If management hedges more on MI450 and mega-deal questions during Q&A (when they can't control the narrative), this supports my DCF's assumption of ~1 quarter MI450 delay and 75% (not 95%) mega-deal realization.

**Why:** The sentiment data provides a quantitative signal that management is less confident about execution details than the headline tone score (82/100) suggests. This supports my base case assumptions against both the bull case and the Catalyst Analyst's 75% on-time probability.

**Impact on conclusion:** Reinforces the base case scenario weights rather than changing them. Provides qualitative support for the 50% base case probability vs. a higher bull case weighting.

**Severity: Low**

---

### 4. What's Strong

The identification that GPU revenue opacity "suggests GPU-specific economics may be less compelling than the blended Data Center segment" is a critical insight. If GPU gross margins are lower than blended DC margins (which is plausible given TSMC advanced packaging costs and competitive pricing pressure from NVIDIA), my terminal gross margin assumption of 57.5% may be too high as GPU becomes a larger share of the mix.

---

---

## Critique of Technical Analyst's Work Product

### 1. Weakest Assumption

**Assumption identified:** "Measured move from $200-$267 range breakdown projects to ~$133 (maximum) or ~$165 (conservative)"

**Why it's weak:** The measured move technique assumes the current breakdown from the $200-267 range will mirror the range's magnitude. But this is a mechanical pattern projection that ignores fundamentals entirely. My DCF base case of $155 is close to the conservative measured move target of $165, which provides some independent convergence — but the $133 maximum target implies a P/E of ~23x on FY2026E EPS, which would require either a significant earnings miss or a broad market correction. The Technical Analyst doesn't distinguish between these scenarios.

**Quantified impact if wrong:** If the stock finds support at $165-185 (as the Technical Analyst suggests) rather than falling to $133, the downside from current $190 is -3% to -13% — much less severe than my DCF bear case implies. This suggests the technical support zone could limit near-term downside even if fundamentals deteriorate.

**Severity: Low**

---

### 2. Most Likely Source of Error

**Error source identified:** All technical analysis is based on WebSearch data rather than computed from actual historical price series. The Technical Analyst acknowledges: "Historical price data NOT available from Research Analyst — tool error."

**Why this is the most likely error:** Without actual price data, the moving averages, RSI, and MACD values are sourced from third-party websites (Barchart, Investing.com) that may use different calculation parameters or time periods. The 50-day MA of $241.84 vs. 200-day MA of $228.48, for example — if these are from different sources or different dates, the death cross timing estimate (4-8 weeks) could be off.

**Suggested correction:** Flag all technical levels with source dates and acknowledge that the analysis is based on point-in-time snapshots rather than continuous data analysis. For the Director, the key takeaway should be the trend direction (bearish) rather than specific price levels.

**Severity: Low**

---

### 3. Recommended Change

**What I'd change:** Reconcile the technical targets with DCF fair values. The $165 conservative measured move target is close to my base case $155, while the $133 maximum target is between my base and bear cases. The Technical Analyst should note: "DCF base case ($155) aligns with the $165 conservative technical target, providing cross-methodology convergence on fair value support."

**Why:** The convergence between technical and fundamental targets is the most useful signal from the technical analysis for the Director's final call. If two independent methodologies (DCF at $155 and technicals at $165) agree on a fair value zone, conviction in that range increases.

**Impact on conclusion:** Would strengthen the Director's confidence in the $155-165 fair value range without changing either analysis.

**Severity: Low**

---

### 4. What's Strong

The observation that AMD has 30%+ drawdowns ~1.5x per year is directly relevant to position sizing and validates the Risk Analyst's drawdown estimates. Combined with my DCF's 0.31x upside/downside ratio, this strongly supports a reduced position size regardless of conviction level.

---

---

## Critique of Sector Analyst's Work Product

### 1. Weakest Assumption

**Assumption identified:** "AI GPU TAM: $140B (2025) → $378B (2030 base, 22% CAGR)" [ESTIMATED] and "TAM estimates have historical tendency to overstate by 20-40% in growth sectors"

**Why it's weak:** The Sector Analyst correctly flags that TAM estimates historically overstate by 20-40%, but then uses the unadjusted $378B figure as the base case. If we apply the Sector Analyst's own 30% overstatement discount, the AI GPU TAM becomes ~$265B by 2030. At my modeled AMD share of 18.8%, this gives AMD AI GPU revenue of ~$50B instead of ~$71B ($378B x 18.8%). My DCF models total DC revenue of $73.1B in FY2030 — the TAM-adjusted figure would reduce this to ~$55-60B, which is closer to my bear case.

**Quantified impact if wrong:** A 30% TAM overstatement would reduce my base case FY2030 DC revenue from $73.1B to ~$55B, cutting base case fair value from $154.58 to approximately $115-120 — a massive ~$35-40/share impact.

**Severity: High**

---

### 2. Most Likely Source of Error

**Error source identified:** "TSMC CoWoS: ~80,000 wafers/month, >100% utilization; NVIDIA ~60% allocation, AMD ~8-10%"

**Why this is the most likely error:** My DCF models AMD GPU revenue growing from $8.3B to $23.1B (FY2025-FY2030), implying ~2.8x growth in GPU volume (assuming flat ASPs, more with ASP growth). But if AMD's CoWoS allocation is only 8-10% vs. NVIDIA's 60%, AMD may be supply-constrained before it becomes demand-constrained. TSMC expanding to 130,000 wafers/month by late 2026 helps, but if AMD's share stays at 8-10%, that's only ~13,000 wafers/month — potentially insufficient to fulfill mega-deal commitments. This is a constraint my DCF does not model.

**Suggested correction:** Estimate the wafer count required for AMD's mega-deal commitments and compare to likely CoWoS allocation. If there's a gap, reduce the mega-deal realization rate or extend the revenue ramp timeline.

**Severity: High**

---

### 3. Recommended Change

**What I'd change:** The Sector Analyst's AMD ROIC estimate of ~15% seems inconsistent with the Quant Analyst's ROIC of 6.6%. The discrepancy is large (8.4pp) and likely reflects different capital base definitions (with/without goodwill from Xilinx). The Sector Analyst should specify whether the 15% ROIC excludes Xilinx goodwill — if so, it's a "clean" ROIC that better reflects operating performance, but investors own the actual balance sheet including goodwill.

**Why:** ROIC relative to WACC determines whether AMD creates or destroys value. At ROIC 6.6% vs. WACC 16%, AMD is a value destroyer. At ROIC 15% vs. WACC 16%, AMD is approximately breaking even. These are fundamentally different conclusions about the franchise's economic value.

**Impact on conclusion:** If ROIC is genuinely 6.6% (as the Quant Analyst calculates), my DCF's terminal growth rate assumption of 3.0% may be too aggressive — a company earning below its WACC should not grow at above-GDP rates at terminal maturity.

**Severity: Medium**

---

### 4. What's Strong

The TSMC CoWoS supply constraint analysis is the most important supply-side insight in the swarm. My DCF is entirely demand-focused — the Sector Analyst correctly identifies that supply (not demand) may be the binding constraint on AMD's GPU ramp. This is a genuine blind spot in my model.

---

---

## Summary of Cross-Critique Themes

### Highest-Severity Issues (Would Materially Change Investment Conclusion)

1. **Risk Analyst's $210 EV vs. my $154 DCF** — $56/share gap (36% divergence) must be reconciled before the Director can set a price target.
2. **Quant Analyst's NTM EBITDA margin assumption** — Using 27% instead of forward 32.5% artificially inflates EV/EBITDA, making AMD appear more expensive than warranted.
3. **Sector Analyst's TAM overstatement acknowledgment but non-adjustment** — If TAM is overstated by 30% (the Sector Analyst's own estimate), my base case fair value drops ~$35-40/share.
4. **TSMC CoWoS supply constraint** — My DCF is entirely demand-side; if supply is the binding constraint, mega-deal realization rates should be lower.
5. **Sentiment Analyst's GPU revenue opacity** — My entire DC GPU revenue build ($8.3B FY2025 → $23.1B FY2030) rests on an [ESTIMATED] GPU revenue split that AMD refuses to disclose.

### Consistent Findings Across Analysts (High Confidence)

1. **Warrant dilution is punitive** — DCF, ESG, DA, and Risk Analysts all converge on 9-20% expected dilution.
2. **MI450 timing is genuinely uncertain** — DCF, Catalyst, DA, and Competitive Analysts all flag H2 2026 as uncertain.
3. **CUDA/ROCm gap is the structural constraint** — Competitive, Sector, DA, and Sentiment Analysts all flag this.
4. **Credit/balance sheet is a non-issue** — Credit and Forensic Analysts agree; consistent with my DCF bear case being driven by revenue/margins, not solvency.

---

*Critiques by DCF Analyst, Equity Research Swarm. Pass 2 adversarial review.*
